Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
  • A61K31/19—Carboxylic acids, e.g. valproic acid
  • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
  • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
  • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
  • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
  • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P13/00—Drugs for disorders of the urinary system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P13/00—Drugs for disorders of the urinary system
  • A61P13/12—Drugs for disorders of the urinary system of the kidneys
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/04—Centrally acting analgesics, e.g. opioids
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P3/00—Drugs for disorders of the metabolism
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
  • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
  • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
  • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
  • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
  • G01N33/6806—Determination of free amino acids
  • G01N33/6812—Assays for specific amino acids

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Engineering & Computer Science (AREA)
• General Health & Medical Sciences (AREA)
• Medicinal Chemistry (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• Pharmacology & Pharmacy (AREA)
• Animal Behavior & Ethology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Molecular Biology (AREA)
• Biomedical Technology (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Organic Chemistry (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Epidemiology (AREA)
• Hematology (AREA)
• Urology & Nephrology (AREA)
• Immunology (AREA)
• Physics & Mathematics (AREA)
• Emergency Medicine (AREA)
• Microbiology (AREA)
• Pathology (AREA)
• Food Science & Technology (AREA)
• General Physics & Mathematics (AREA)
• Biochemistry (AREA)
• Analytical Chemistry (AREA)
• Cell Biology (AREA)
• Bioinformatics & Computational Biology (AREA)
• Biophysics (AREA)
• Biotechnology (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Neurology (AREA)
• Neurosurgery (AREA)
• Hospice & Palliative Care (AREA)
• Diabetes (AREA)
• Psychiatry (AREA)
• Otolaryngology (AREA)

Applications Claiming Priority (1)

Publications (1)

Family

ID=49380684

Family Applications (2)

Family Applications After (1)

Country Status (25)

Families Citing this family (8)

Family Cites Families (25)

• 2012
  • 2012-09-11 PT PT128747458T patent/PT2846791T/pt unknown
  • 2012-09-11 KR KR1020147032114A patent/KR20150013170A/ko not_active Withdrawn
  • 2012-09-11 ES ES17154858T patent/ES2807951T3/es active Active
  • 2012-09-11 CN CN201280074143.6A patent/CN104540507A/zh active Pending
  • 2012-09-11 ES ES12874745.8T patent/ES2623470T3/es active Active
  • 2012-09-11 LT LTEP12874745.8T patent/LT2846791T/lt unknown
  • 2012-09-11 DK DK12874745.8T patent/DK2846791T3/en active
  • 2012-09-11 RS RS20170421A patent/RS55870B1/sr unknown
  • 2012-09-11 HU HUE12874745A patent/HUE032726T2/en unknown
  • 2012-09-11 SI SI201230933A patent/SI2846791T1/sl unknown
  • 2012-09-11 MX MX2014012694A patent/MX365302B/es active IP Right Grant
  • 2012-09-11 EP EP17154858.9A patent/EP3222275B1/en active Active
  • 2012-09-11 KR KR1020197029026A patent/KR102264579B1/ko active Active
  • 2012-09-11 CN CN202010449455.7A patent/CN111991383A/zh active Pending
  • 2012-09-11 BR BR112014026138A patent/BR112014026138A2/pt not_active Application Discontinuation
  • 2012-09-11 SG SG11201406745VA patent/SG11201406745VA/en unknown
  • 2012-09-11 SM SM20170219T patent/SMT201700219T1/it unknown
  • 2012-09-11 EP EP12874745.8A patent/EP2846791B1/en active Active
  • 2012-09-11 JP JP2015506953A patent/JP6234436B2/ja active Active
  • 2012-09-11 US US13/610,580 patent/US9561197B2/en active Active
  • 2012-09-11 CN CN202111191403.5A patent/CN113995743A/zh active Pending
  • 2012-09-11 HR HRP20170651TT patent/HRP20170651T1/hr unknown
  • 2012-09-11 SG SG10201608749UA patent/SG10201608749UA/en unknown
  • 2012-09-11 WO PCT/US2012/054673 patent/WO2013158145A1/en not_active Ceased
  • 2012-09-11 PL PL12874745T patent/PL2846791T3/pl unknown
  • 2012-09-11 AU AU2012377389A patent/AU2012377389A1/en not_active Abandoned
• 2014
  • 2014-10-17 CL CL2014002807A patent/CL2014002807A1/es unknown
  • 2014-10-19 IL IL235127A patent/IL235127A/en active IP Right Grant
  • 2014-10-20 ZA ZA2014/07597A patent/ZA201407597B/en unknown
  • 2014-10-27 EC ECIEPI201424561A patent/ECSP14024561A/es unknown
• 2017
  • 2017-01-10 US US15/402,780 patent/US20170266143A1/en not_active Abandoned
  • 2017-04-20 CY CY20171100449T patent/CY1118838T1/el unknown
  • 2017-05-30 CL CL2017001375A patent/CL2017001375A1/es unknown
  • 2017-08-25 US US15/687,136 patent/US20180015058A1/en not_active Abandoned
  • 2017-10-24 JP JP2017204831A patent/JP6637941B2/ja active Active
  • 2017-11-26 IL IL255918A patent/IL255918B/en active IP Right Grant
• 2018
  • 2018-01-09 AU AU2018200163A patent/AU2018200163B2/en active Active
  • 2018-05-15 US US15/980,431 patent/US20180263938A1/en not_active Abandoned
• 2019
  • 2019-03-15 AU AU2019201811A patent/AU2019201811B2/en active Active
  • 2019-08-19 JP JP2019149843A patent/JP2019219413A/ja active Pending

Also Published As

Similar Documents